The Gabelli Healthcare & Wellness Trust (GRX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Gabelli Healthcare & Wellness Trust (GRX) trades at $9.66 with AI Score 60/100 (Grade B+). The Gabelli Healthcare & Wellness Trust is a closed-end equity mutual fund focusing on the healthcare and wellness sectors globally. Market cap: $145.39M, Sector: Financial services.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for GRX: GRX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GRX against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
GRX: 3/4 perspectives are bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →The Gabelli Healthcare & Wellness Trust (GRX) Financial Services Profile
The Gabelli Healthcare & Wellness Trust is a closed-end fund specializing in global healthcare and wellness equities. Managed by Gabelli Funds, it offers investors exposure to a diversified portfolio within these sectors. With a focus on companies across all market capitalizations, GRX benchmarks against key S&P indices, providing a dividend yield of 7.08% and operating with a beta of 0.89.
What Is the Investment Thesis for GRX?
The Gabelli Healthcare & Wellness Trust presents an investment opportunity centered on the growing healthcare and wellness sectors. With a dividend yield of 7.08%, GRX offers income potential alongside capital appreciation. The fund's focus on global healthcare and wellness companies provides diversification and exposure to innovative and growing segments of the market. The fund's profit margin of 15.0% indicates operational efficiency. Upcoming catalysts include the aging global population and increasing demand for healthcare services, which are expected to drive growth in the sector. However, potential risks include regulatory changes and market volatility, which could impact the fund's performance. The fund's beta of 0.89 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
GRX Key Highlights
- Market Cap of $145.39M indicates the size and scale of the fund's investments.
- P/E ratio of 62.38 reflects the valuation of the fund relative to its earnings.
- Profit Margin of 15.0% demonstrates the fund's profitability in its investment activities.
- Gross Margin of 34.2% shows the efficiency of the fund's investment strategies.
- Dividend Yield of 7.08% provides income to investors, making it a noteworthy option for income-seeking investors.
Who Are GRX's Competitors?
GRX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BCV Bancroft Fund Ltd. | $25.54 | +1.57% | $148.73M | 48 |
| BHCFX Baron Health Care Fund Retail Shares | $22.33 | +2.01% | $109.42M | 44 |
| DMO Western Asset Mortgage Opportunity Fund Inc. | $10.69 | -0.33% | $122.10M | 46 |
| GGT The Gabelli Multimedia Trust Inc. | $4.21 | +0.12% | $175.81M | 68 |
| ICPAX Integrity Mid-North American Resources Fund Class A | $8.54 | -0.58% | $196.82M | 50 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GRX's Key Strengths?
- Experienced management team with expertise in healthcare and wellness investing.
- Global investment strategy providing diversification.
- Closed-end fund structure allowing for long-term investment horizon.
- Attractive dividend yield for income-seeking investors.
What Are GRX's Weaknesses?
- Relatively small market capitalization compared to larger asset managers.
- Concentration in the healthcare and wellness sectors, which can be subject to regulatory and market risks.
- Potential for NAV discount compared to underlying asset value.
- Dependence on the performance of the healthcare and wellness sectors.
What Could Drive GRX Stock Higher?
- Aging population driving increased demand for healthcare services and products.
- Technological advancements in healthcare creating new investment opportunities.
- Increasing consumer interest in wellness and preventative care.
- Potential for new drug approvals and medical breakthroughs in the healthcare sector.
- Expansion of healthcare services in emerging markets.
What Are the Key Risks for GRX?
- Financial-distress signal — its Altman Z-Score of 1.50 sits in the distress zone (elevated bankruptcy risk).
- Regulatory changes and healthcare reforms impacting the profitability of healthcare companies.
- Market volatility and economic downturns affecting the performance of equity markets.
- Competition from other asset managers offering similar investment strategies.
- Changes in consumer preferences and trends in the wellness sector.
- Interest rate fluctuations impacting the value of fixed income investments.
What Are the Growth Opportunities for GRX?
- Aging Global Population: The aging global population is a significant growth driver for the healthcare and wellness sectors. As the population ages, the demand for healthcare services, pharmaceuticals, and wellness products increases. This trend is expected to continue over the next several decades, providing a long-term growth opportunity for GRX. The global aging population is estimated to reach over 2 billion by 2050, creating a substantial market for healthcare and wellness companies.
- Technological Advancements in Healthcare: Technological advancements in healthcare, such as telemedicine, digital health, and AI-powered diagnostics, are transforming the industry. These innovations are improving healthcare delivery, reducing costs, and enhancing patient outcomes. GRX can capitalize on this trend by investing in companies that are at the forefront of these technological advancements. The digital health market is projected to reach hundreds of billions of dollars in the coming years, offering significant growth potential.
- Increasing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, such as diabetes, heart disease, and cancer, is driving demand for healthcare services and products. GRX can benefit from this trend by investing in companies that are developing innovative treatments and therapies for these diseases. The global market for chronic disease management is expected to grow substantially in the coming years, presenting a significant opportunity for GRX.
- Growing Consumer Interest in Wellness: Growing consumer interest in wellness, including fitness, nutrition, and mental health, is creating a large and growing market for wellness products and services. GRX can capitalize on this trend by investing in companies that are catering to this growing demand. The global wellness market is estimated to be worth trillions of dollars, offering a diverse range of investment opportunities.
- Expansion into Emerging Markets: Emerging markets, such as China, India, and Brazil, are experiencing rapid economic growth and increasing access to healthcare. This presents a significant growth opportunity for GRX, as these markets offer untapped potential for healthcare and wellness companies. Investing in these markets can provide GRX with exposure to high-growth opportunities and diversification benefits. The healthcare market in emerging markets is projected to grow at a faster rate than in developed markets, making it an attractive area for investment.
What Opportunities Does GRX Have?
- Growing demand for healthcare and wellness products and services due to aging population and increasing health awareness.
- Technological advancements in healthcare creating new investment opportunities.
- Expansion into emerging markets with increasing access to healthcare.
- Potential for increased investor interest in thematic investing focused on healthcare and wellness.
What Threats Does GRX Face?
- Regulatory changes and healthcare reforms impacting the profitability of healthcare companies.
- Market volatility and economic downturns affecting the performance of equity markets.
- Competition from other asset managers offering similar investment strategies.
- Changes in consumer preferences and trends in the wellness sector.
What Are GRX's Competitive Advantages?
- Established brand and reputation of Gabelli Funds.
- Expertise in healthcare and wellness sector investing.
- Global investment strategy providing diversification.
- Closed-end fund structure allowing for long-term investment horizon.
What Does GRX Do?
The Gabelli Healthcare & Wellness Trust (GRX) was established on February 20, 2007, and is domiciled in the United States. As a closed-end equity mutual fund, GRX is managed by Gabelli Funds, LLC, under the umbrella of GAMCO Investors, Inc. The trust's primary investment objective is to seek long-term capital appreciation by investing in a portfolio of companies operating within the healthcare and wellness sectors. This includes pharmaceuticals, biotechnology, medical devices, healthcare services, and companies involved in health and wellness-related consumer products and services. GRX invests across the globe, providing a diversified approach to accessing opportunities in the healthcare and wellness markets. The fund invests in companies across all market capitalizations, from small-cap to large-cap, allowing flexibility in capturing growth potential. The fund's performance is benchmarked against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index, providing a basis for evaluating its investment strategy and results. GRX aims to deliver value to its shareholders through a combination of capital appreciation and dividend income, reflecting the potential of the healthcare and wellness sectors.
What Products and Services Does GRX Offer?
- Invests in publicly traded companies.
- Focuses on the healthcare sector.
- Targets the wellness sector.
- Operates as a closed-end fund.
- Manages a portfolio of equity securities.
- Seeks long-term capital appreciation.
- Benchmarks performance against S&P indices.
How Does GRX Make Money?
- Generates revenue through investment management fees.
- Earns income from dividends and capital gains from portfolio holdings.
- Utilizes a global investment strategy to identify opportunities.
- Actively manages its portfolio to maximize returns.
What Industry Does GRX Operate In?
The Gabelli Healthcare & Wellness Trust operates within the asset management industry, focusing specifically on the healthcare and wellness sectors. These sectors are experiencing growth driven by factors such as an aging global population, increasing prevalence of chronic diseases, and growing consumer interest in health and wellness. The competitive landscape includes other closed-end funds, ETFs, and mutual funds that focus on healthcare and wellness. GRX differentiates itself through its global investment approach and active management style, seeking to identify undervalued opportunities within these sectors. The global healthcare market is projected to reach trillions of dollars in the coming years, presenting significant growth potential for funds like GRX.
Who Are GRX's Key Customers?
- Individual investors seeking exposure to the healthcare and wellness sectors.
- Institutional investors looking for diversified investment opportunities.
- Financial advisors seeking investment solutions for their clients.
- Retirement funds and endowments.
F-Score 6/9Financial Health
The Gabelli Healthcare & Wellness Trust's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.50 places it in the distress zone, a signal of elevated financial risk.
ROE 1%Key Financial Metrics
Return on equity for The Gabelli Healthcare & Wellness Trust stands at 1.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. GRX trades at a trailing price-to-earnings ratio of 60.77, above the Financial Services sector average of ~18x. Its free cash flow yield is 6.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 1.6%, the inverse of the P/E and a quick read on earnings relative to price.
The Gabelli Healthcare & Wellness Trust (GRX) Valuation Context
Valued at $145.39M, GRX is classified as a micro-cap stock. Relative to its peer group, GRX's quantitative score of 60/100 is roughly in line with the peer average of 51/100.
GRX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's long-term prospects, indicating that key stakeholders see value in the current price.
- Community sentiment has shifted positively, with discussions highlighting the increasing demand for healthcare and wellness products as consumers prioritize health.
- The company has been actively diversifying its portfolio, which may enhance resilience against market fluctuations and position it for growth.
- Recent news coverage has focused on the potential for healthcare innovation, which could benefit companies like Gabelli that are aligned with these trends.
Bear Case
- Concerns about valuation persist, as some investors believe the stock may be overvalued given current market conditions.
- The overall market sentiment has been cautious, with many traders expressing skepticism about the sustainability of recent gains in the healthcare sector.
- There has been a notable increase in bearish commentary within trading communities, reflecting doubts about the company's ability to deliver consistent returns.
- Potential regulatory changes in the healthcare sector could pose risks, leading some investors to adopt a wait-and-see approach before committing capital.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GRX Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Oct 3, 2023
-
Stocks That Hit 52-Week Lows On Tuesday
benzinga · Oct 11, 2022
-
Stocks That Hit 52-Week Highs On Friday
· Jun 11, 2021
-
Stocks That Hit 52-Week Highs On Wednesday
· Feb 10, 2021
GRX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRX.
Price Targets
Wall Street price target analysis for GRX.
GRX MoonshotScore
What does this score mean?
The MoonshotScore rates GRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Wayne Christopher Pinsent
CEO
Wayne Christopher Pinsent serves as CEO. His background encompasses extensive experience in financial services and investment management. He has held various leadership positions, demonstrating expertise in portfolio management, asset allocation, and investment strategy. Pinsent's career reflects a commitment to delivering value to shareholders through strategic decision-making and effective risk management. His experience includes roles at leading financial institutions, where he focused on developing and implementing investment strategies across different asset classes. Pinsent's educational background includes advanced degrees in finance and economics, providing a strong foundation for his leadership role.
Track Record: Under Wayne Christopher Pinsent's leadership, The Gabelli Healthcare & Wellness Trust has maintained a focus on delivering consistent returns to shareholders through strategic investments in the healthcare and wellness sectors. Key achievements include navigating market volatility and adapting the fund's portfolio to capitalize on emerging trends. Pinsent's tenure has been marked by a commitment to disciplined investment processes and a focus on long-term value creation.
The Gabelli Healthcare & Wellness Trust Financial Services Stock: Key Questions Answered
What does The Gabelli Healthcare & Wellness Trust do?
The Gabelli Healthcare & Wellness Trust is a closed-end investment fund that focuses on investing in companies within the healthcare and wellness sectors globally. Managed by Gabelli Funds, LLC, the trust aims to provide investors with long-term capital appreciation and income by strategically allocating capital to companies involved in pharmaceuticals, biotechnology, medical devices, healthcare services, and wellness-related consumer products. The fund actively manages its portfolio, seeking to identify undervalued opportunities and capitalize on growth trends within these sectors. GRX benchmarks its performance against key S&P indices to ensure competitive returns for its shareholders.
What are the main risks for GRX?
The Gabelli Healthcare & Wellness Trust faces several risks inherent to its investment strategy and the sectors it targets. Regulatory changes in the healthcare industry, such as drug pricing reforms or changes to healthcare policies, could negatively impact the profitability of companies in the portfolio. Market volatility and economic downturns could also affect the fund's performance, as equity markets can be sensitive to macroeconomic factors. Additionally, competition from other asset managers offering similar investment strategies could put pressure on the fund's returns. Changes in consumer preferences and trends in the wellness sector could also impact the performance of companies in the portfolio. Interest rate fluctuations may also impact the fund's performance.
How does The Gabelli Healthcare & Wellness Trust generate revenue?
The Gabelli Healthcare & Wellness Trust primarily generates revenue through investment management fees charged to its investors. These fees are typically a percentage of the fund's net asset value (NAV) and are used to cover the costs of managing the fund, including research, portfolio management, and administrative expenses. Additionally, the fund generates revenue from dividends and capital gains realized from its portfolio holdings. These income streams contribute to the fund's overall performance and are ultimately passed on to investors in the form of dividends and capital appreciation. The fund's ability to generate revenue is dependent on its investment performance and its ability to attract and retain investors.
What is The Gabelli Healthcare & Wellness Trust's credit quality and risk management approach?
As a closed-end equity fund, The Gabelli Healthcare & Wellness Trust does not directly engage in lending or credit activities. Therefore, credit quality assessment is not directly applicable. However, the fund's risk management approach involves diversifying its investments across different companies and sectors within the healthcare and wellness industries. The fund also conducts thorough research and due diligence on its potential investments to assess their financial health, competitive positioning, and growth prospects. The fund's management team actively monitors market conditions and adjusts the portfolio as needed to mitigate risks and capitalize on opportunities. The fund's closed-end structure allows for a long-term investment horizon, which can help to reduce the impact of short-term market fluctuations.
What are the key factors to evaluate for GRX?
The Gabelli Healthcare & Wellness Trust (GRX) holds an AI score of 60/100 (moderate). Not financial advice.
How frequently does GRX data refresh on this page?
GRX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GRX's recent stock price performance?
The Gabelli Healthcare & Wellness Trust (GRX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team with expertise in healthcare and wellness investing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GRX overvalued or undervalued right now?
Valuing The Gabelli Healthcare & Wellness Trust (GRX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available financial data and company descriptions.
- AI analysis pending for GRX may provide additional insights in the future.